Conjugated Linoleic Acid (CLA)

DIETARY_SUPPLEMENT4 trials

Sponsors

Ohio State University, University of British Columbia, Dartmouth-Hitchcock Medical Center

Conditions

AsthmaBreast CancerDiabetes MellitusType 2 Diabetes Mellitus

Early Phase 1

Proof of Principle Trial to Determine if Nutritional Supplement Conjugated Linoleic Acid (CLA) Can Modulate the Lipogenic Pathway in Breast Cancer Tissue

CompletedNCT00908791

Dartmouth-Hitchcock Medical CenterBreast Cancer

Start: 2009-06-30End: 2013-03-31Updated: 2019-04-01

Phase 1

Dietary Fatty Acids As Complementary Therapy in Type 2 Diabetes Mellitus

CompletedNCT00607945

Ohio State UniversityType 2 Diabetes Mellitus

Start: 2008-01-31End: 2012-05-31Updated: 2024-10-29

Unknown Phase

The Health Benefits of Conjugated Linoleic Acid (CLA) for Asthma & Allergy

CompletedNCT00876356

University of British ColumbiaAsthma

Start: 2002-05-31End: 2004-09-30Updated: 2009-04-06

Supplementation With Conjugated Linoleic Acid (CLA) as Complementary Therapy in the Management of Type 2 Diabetes Mellitus (Women's Diabetes Study)

CompletedNCT01121471

Ohio State UniversityDiabetes Mellitus

Start: 2004-12-31End: 2006-11-30Updated: 2010-05-12